# The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging

> **NCT05307627** · — · WITHDRAWN · sponsor: **AgelessRx**

## Conditions studied

- Aging

## Interventions

- **DRUG:** low-dose naltrexone

## Key facts

- **NCT ID:** NCT05307627
- **Lead sponsor:** AgelessRx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-03-14
- **Primary completion:** 2023-12-14
- **Final completion:** 2023-12-14
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Technological barriers are affecting the participant response experience.
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05307627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05307627, "The Effects of Low Dose Naltrexone (LDN) on Diseases of Aging". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05307627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*